Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrially encoded tRNA asparagine (MT-TN) is a 73-nucleotide RNA molecule encoded by the MT-TN gene of human mitochondrial DNA[1]. MT-TN transfers the amino acid asparagine to the growing polypeptide chain at the ribosome during mitochondrial protein synthesis. Mutations in MT-TN are associated with mitochondrial diseases including isolated ophthalmoplegia and cytochrome c oxidase deficiency, reflecting its essential role in the oxidative phosphorylation machinery and cellular energy production[1][2]. Mature mitochondrial tRNAs undergo a unique maturation process involving endoribonucleases, methyltransferases, and nucleotidyltransferases, ensuring correct folding and function in the structurally degenerate environment of the mitochondria[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrially encoded tRNA asparagine (MT-TN).